Zobrazeno 1 - 6
of 6
pro vyhledávání: '"João M. Araujo-Neto"'
Autor:
Luiz F. Viola, Cynthia M. Valerio, João M. Araujo-Neto, Fabio F. Santos, Felipe Matsuura, Rodrigo O. Moreira, Amélio F. Godoy-Matos
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-7 (2023)
Abstract Background Lipodystrophies are a heterogeneous group of diseases characterized by the selective loss of subcutaneous adipose tissue and ectopic fat deposition in different organs, including the liver. This study aimed to determine the freque
Externí odkaz:
https://doaj.org/article/f30c4f1e8f354ae88d6c845daffb15c0
Autor:
Cristiane V. Tovo, Cristiane A. Villela-Nogueira, Nathalie C. Leite, Carine L. Panke, Gabriela Z. Port, Sabrina Fernandes, Caroline Buss, Gabriela P. Coral, Ana C. Cardoso, Claudia M. Cravo, Fernanda L. Calçado, Guilherme F.M. Rezende, Frederico C. Ferreira, João M. Araujo-Neto, Renata de M. Perez, Henrique S. Moraes-Coelho, Angelo A. de Mattos
Publikováno v:
Annals of Hepatology, Vol 18, Iss 3, Pp 445-449 (2019)
Introduction and aim: The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease (NAFLD) is liver biopsy, despite its invasive approach, sampling limitations and variability among observers. The objective was to validate the perfor
Externí odkaz:
https://doaj.org/article/23ebde1b41d1466189fb588accfb389a
Autor:
Claudia M. Cravo, Gabriela Z. Port, Nathalie C. Leite, Guilherme Ferreira da Motta Rezende, Caroline Buss, Cristiane Valle Tovo, Angelo Alves de Mattos, Cristiane A. Villela-Nogueira, Frederico C. Ferreira, Renata M. Perez, João M. Araujo-Neto, Henrique S. Moraes-Coelho, Sabrina Alves Fernandes, Ana Carolina Cardoso, Gabriela Perdomo Coral, Fernanda Luiza Calçado, Carine Panke
Publikováno v:
Annals of Hepatology, Vol 18, Iss 3, Pp 445-449 (2019)
Introduction and aim The gold-standard for fibrosis diagnosis in non-alcoholic fatty liver disease (NAFLD) is liver biopsy, despite its invasive approach, sampling limitations and variability among observers. The objective was to validate the perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9153d2e02c5638733c9f1a2d2ec48289
https://pubmed.ncbi.nlm.nih.gov/31031166
https://pubmed.ncbi.nlm.nih.gov/31031166
Autor:
Eduardo Mastrangelo Marinho Falcão, Leonardo Hoehl Carneiro, Cristiane Alves Villela Nogueira, Marcia Ramos-e-Silva, Mariana Marteleto Godinho, Beatriz Moritz Trope, João M. Araujo-Neto
Publikováno v:
Case Reports in Dermatology, Vol 7, Iss 3, Pp 253-262 (2015)
Case Reports in Dermatology
Case Reports in Dermatology
Hepatitis C virus (HCV) chronically infects 0.5-3% of the world population. A large group of patients develop cirrhosis and its complications. Since 2011, telaprevir and boceprevir are used, improving the disease evolution. One of the main side effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4004c6fcf921ca787cef855e4566f30
http://www.karger.com/Article/FullText/439264
http://www.karger.com/Article/FullText/439264
Autor:
Renata M. Perez, Maria Chiara Chindamo, Cristiane A. Villela-Nogueira, Henrique S. Moraes-Coelho, Vera L Nunes-Pannain, João M. Araujo-Neto, Ronir Raggio Luiz
Publikováno v:
Annals of Hepatology, Vol 14, Iss 5, Pp 652-657 (2015)
Background and aims. The prediction of intermediate stage of fibrosis in chronic hepatitis C represents a prognostic factor for disease progression. Studies evaluating biopsy performance in intermediate stage considering current patterns of liver sam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d0f617b123f3ea5b8ab2f9666f73cf5
http://www.sciencedirect.com/science/article/pii/S1665268119307598
http://www.sciencedirect.com/science/article/pii/S1665268119307598
Autor:
Maria C. Chindamo, M.D., Ph.D., Vera L. Nunes-Pannain, João M. Araújo-Neto, Henrique S. Moraes-Coelho, Ronir R. Luiz, Cristiane A. Villela-Nogueira, Renata M. Perez
Publikováno v:
Annals of Hepatology, Vol 14, Iss 5, Pp 652-657 (2015)
Background and aims. The prediction of intermediate stage of fibrosis in chronic hepatitis C represents a prognostic factor for disease progression. Studies evaluating biopsy performance in intermediate stage considering current patterns of liver sam
Externí odkaz:
https://doaj.org/article/bf0dbac355594de6ba22d042ab17c94b